drugset / Trial / NCT02147691
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
Phase 4
Completed
22 enrolled
Derm Research, PLLC
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.
Timeline
- Start
- 2014-05
- Primary completion
- 2015-01
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azelaic acid | Small molecule | 15 % | Topical |
| Subject | Brimonidine | Small molecule | 0.33 % | Topical |